Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 2

1(20.0%)

5Total

N/A(4)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04904601Not ApplicableCompleted

Freeze-dried Kale to Reduce Metabolic Risk in Saudi Subjects

Role: collaborator

NCT05115747Not ApplicableCompleted

Effect of Alter-G Training on Glycemic Control and Quality of Life in Diabetic Neuropathy

Role: collaborator

NCT05775172Completed

Weight Loss Via Bariatric Surgery and Lifestyle Modification

Role: collaborator

NCT04215354Not ApplicableCompleted

Association Between Fatigue and Balance in Patients With Multiple Sclerosis

Role: collaborator

NCT02256215Phase 2Unknown

Vitamin D in the Treatment of Primary Restless Legs Syndrome

Role: collaborator

NCT01099111Completed

Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders

Role: collaborator

NCT01321788Unknown

Venous Thromboembolism Prophylaxis Post Cesarean Section

Role: collaborator

NCT00426010Not ApplicableCompleted

Measuring Placebo Effect by Elimination and Investigating Mechanism of Action

Role: collaborator

All 8 trials loaded